home / stock / soltf / soltf quote
Last: | $10.5321 |
---|---|
Change Percent: | -4.3% |
Open: | $10.67 |
Close: | $10.5321 |
High: | $10.67 |
Low: | $10.5321 |
Volume: | 600 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$10.5321 | $10.67 | $10.5321 | $10.67 | $10.5321 | 600 | 07-17-2024 |
$10.23 | $10.23 | $10.23 | $10.23 | $10.23 | 56 | 07-16-2024 |
$10.2395 | $10.2395 | $10.2395 | $10.2395 | $10.2395 | 100 | 07-09-2024 |
$9.43 | $9.43 | $9.43 | $9.43 | $9.43 | 50 | 06-20-2024 |
$10 | $10 | $10 | $10 | $10 | 50 | 06-12-2024 |
$9.36 | $9.36 | $9.36 | $9.36 | $9.36 | 800 | 06-04-2024 |
$8.87 | $8.87 | $8.87 | $8.87 | $8.87 | 25 | 05-31-2024 |
$8.85 | $8.85 | $8.85 | $8.85 | $8.85 | 1,000 | 05-30-2024 |
$8.92 | $8.92 | $8.92 | $8.92 | $8.92 | 25 | 05-21-2024 |
$9.724 | $9.61 | $9.724 | $9.78 | $9.6 | 800 | 05-16-2024 |
$9.8 | $9.67 | $9.8 | $9.8 | $9.67 | 1,000 | 05-13-2024 |
$9.816 | $9.816 | $9.816 | $9.816 | $9.816 | 1 | 05-10-2024 |
$9.78 | $9.78 | $9.78 | $9.78 | $9.78 | 100 | 05-09-2024 |
$9.55 | $9.55 | $9.55 | $9.55 | $9.55 | 1 | 05-03-2024 |
$9.3039 | $9.3039 | $9.3039 | $9.3039 | $9.3039 | 300 | 04-30-2024 |
$9.3 | $9.2268 | $9.3 | $9.3 | $9.2268 | 1,465 | 04-26-2024 |
$9.72 | $9.72 | $9.72 | $9.72 | $9.72 | 100 | 04-16-2024 |
$10.44 | $10.44 | $10.44 | $10.44 | $10.44 | 300 | 04-08-2024 |
$9.99 | $10.175 | $9.99 | $10.175 | $9.99 | 1,000 | 04-03-2024 |
$10.8 | $10.59 | $10.8 | $10.8 | $10.59 | 400 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Sosei Co Ltd Ord Company Name:
SOLTF Stock Symbol:
OTCMKTS Market:
Tokyo, Japan and Cambridge, UK, 9 July 2024 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for the 6 months ended 30 June 2024 on Friday, 9 August 2024. The Company will host a live webinar presentation with C...
Tokyo, Japan and Cambridge, UK, 27 June 2024 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565), announces that it has reached an important R&D milestone under its multi-target discovery collaboration with AbbVie targeting neurological diseases, resulting in a payment of US$10 million...
Tokyo, Japan and Cambridge, UK, 18 June 2024 – Nxera Pharma (“Nxera” or “the Company”; TSE 4565), today announces the publication of its Annual Report and its Environment, Social & Governance (ESG) Report for the year ended 31 December 2023. The Annu...